Henry Meds
A cash-pay telehealth service built specifically around compounded GLP-1 medications rather than brand-name products, at a lower headline price than most brand-name programmes.
This is not a review
We have not personally used Henry Meds, so we are not rating quality of care, wait times, or customer service. What follows is Henry Meds’s own published terms, checked against independent reporting where we found it. See our full methodology on the provider directory.
Named as a defendant (under its legal entity, Adonis Health, Inc.) in an April 2025 federal lawsuit filed by Eli Lilly alleging deceptive marketing of compounded tirzepatide/semaglutide products, including undisclosed additives. As of mid-2026 the case remains in active litigation with no final settlement confirmed.
Source: MobiHealthNewsAt a glance
- Access model
- Compounded only
- Medications offered
- Compounded semaglutide (injectable)Compounded oral semaglutide
- Prescriber
- Telehealth clinicians; operates under its legal entity, Adonis Health, Inc.
- Insurance
- Cash-pay model; not built around insurance billing
- Membership / program fee
- Compounded injectable semaglutide advertised around $297/month; oral around $249/month
- Cash-pay from
- ~$249/month
- States served
- Not published in a single state-coverage list — confirm at signup
What that adds up to
Adding Henry Meds's published figures together — $249 everything, bundled — comes to $249 a month on its compounded oral semaglutide.
A membership figure and a medication figure are two different numbers, and the one a provider leads with is usually the smaller of the two. We add both together for every provider in this directory and set the result beside buying direct from the manufacturer, on priced against every other route to a GLP-1.
On compounding
Built entirely around compounded medication. Compounded drugs are not FDA-approved products in their own right; the FDA does not review compounded formulations for safety, effectiveness, or manufacturing quality the way it does an approved drug.
For the fuller regulatory picture — the pending FDA proposal on 503B compounding and what it does and doesn’t affect — see the compounding explainer that sits above every provider we list, Henry Meds included.
Questions people ask before signing up
Every answer below states only what Henry Meds publishes about itself, read on 2026-07-26, plus what is on the public record. We have not used this service and we do not rate it.
- Who writes the prescription at Henry Meds?
- Telehealth clinicians; operates under its legal entity, Adonis Health, Inc.. Every GLP-1 receptor agonist is prescription-only in the United States, so a service that supplies one without an assessment is not operating lawfully, whatever it calls itself. This is Henry Meds's own published description of who evaluates you, read on 2026-07-26.
- Does Henry Meds use compounded medication?
- Yes. Its published offer includes Compounded semaglutide (injectable), Compounded oral semaglutide. A compounded preparation is not a generic and has not been reviewed by the FDA for identity, purity or sterility — that is the difference the price reflects, and it is the reason a compounded price is lower.
- What does Henry Meds actually cost per month?
- Adding Henry Meds's published figures together — $249 everything, bundled — comes to $249 a month on its compounded oral semaglutide. A membership or programme fee and a medication price are two different numbers, and the one a provider leads with is usually the smaller. We add both together for every provider in this directory rather than repeating the advertised figure.
- Does Henry Meds take insurance?
- Cash-pay model; not built around insurance billing. Whether your own plan covers a GLP-1 at all is a separate question from whether a provider will bill it, and it is usually the one that decides the price — many employer plans exclude weight-management medications as a category.
- Is Henry Meds available in my state?
- Not published in a single state-coverage list — confirm at signup. Where a provider does not publish a state list we say so rather than assume nationwide coverage, and this field is read from Henry Meds's own site on 2026-07-26.
- Has Henry Meds been subject to litigation or regulatory action?
- Named as a defendant (under its legal entity, Adonis Health, Inc.) in an April 2025 federal lawsuit filed by Eli Lilly alleging deceptive marketing of compounded tirzepatide/semaglutide products, including undisclosed additives. As of mid-2026 the case remains in active litigation with no final settlement confirmed. We record what is on the public record with a source, and we do not characterise it. An allegation is an allegation until a court says otherwise, and where a case has been dismissed we say that too.
How to reach Henry Meds
Visit Henry Meds’s own site to confirm current pricing, state availability, and eligibility — all of the figures above can change without notice, and only the provider itself has the current version.
Disclosure We earn nothing from this link. We hold no referral, affiliate, or advertising arrangement with this provider, and this listing was compiled from their own published terms. How we’re funded.
How this compares
Other providers with a similar access model or worth contrasting against:
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- Henry Meds — published termsHenry MedsSupports: Access model, medications, prescriber type, insurance, pricing, and state coverage as stated in this profile.
- Named as a defendant (under its legal entity, Adonis Health,…MobiHealthNewsSupports: The regulatory or litigation flag noted above.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.